Brian Finan, head of obesity research at Novo Nordisk, said the company is "excited about the opportunity to advance Embark Biotech's lead programme" and looks forward to "co-creating novel ...
LONDON — An experimental weight loss drug from Novo Nordisk helped patients shed a ... Novo as companies race to develop next-generation obesity treatments. Shares of Novo were up more than ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback